Recombinant Leukocyte A Interferon: An Active Agent in Advanced Cutaneous T-Cell Lymphomas
Authors:
- 1 October 1984
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 101 (4) , 484-487
Abstract
High-dose recombinant leukocyte A interferon (50 X 10(6) U/m2 body surface area, intramuscularly, three times weekly) was tested in a clinical trial involving patients with advanced cutaneous T-cell lymphomas to determine its effectiveness and toxicity. All 20 patients had advanced stages of disease refractory to two or more standard therapies. Objective partial remissions lasting 3 months to more than 25 months (median, 5 months) were documented in 9 patients. The major dose-limiting toxicity was a severe influenza-like syndrome with malaise, anorexia, depression, weight loss, and decreased performance status; this effect was reversible after dose reductions in all patients and did not recur with re-escalation of doses in 10 patients. This interferon preparation is highly effective in the treatment of advanced refractory cutaneous T-cell lymphomas, and new schedules to reduce toxicity and achieve complete responses, combined treatment with chemotherapy or serotherapy, and its use in earlier stages of disease should be investigated.Keywords
This publication has 16 references indexed in Scilit:
- Acute Interstitial Nephritis with the Nephrotic Syndrome Following Recombinant Leukocyte A Interferon Therapy for Mycosis FungoidesNew England Journal of Medicine, 1984
- Clinical Course of Retrovirus-Associated Adult T-Cell Lymphoma in the United StatesNew England Journal of Medicine, 1983
- TREATMENT OF CUTANEOUS T-CELL LYMPHOMA (MYCOSIS FUNGOIDES) WITH 13-CIS-RETINOIC ACIDThe Lancet, 1983
- Phenotypic Characterization of Cutaneous T-Cell LymphomaNew England Journal of Medicine, 1981
- Treatment of Cutaneous T‐Cell LymphomaThe Journal of Dermatologic Surgery and Oncology, 1980
- The treatment of mycosis fungoides.Adjuvant topical mechlorethamine after electron beam therapyCancer, 1977
- Malignant lymphoma of peripheral T-lymphocyte origin.Immunologic, pathologic, and clinical features in six patientsCancer, 1977
- The Sézary syndrome: a malignant proliferation of helper T cells.Journal of Clinical Investigation, 1976
- MANAGEMENT OF MYCOSIS FUNGOIDES—CURRENT STATUS AND FUTURE PROSPECTSMedicine, 1975
- MYCOSIS FUNGOIDESMedicine, 1972